Market research on the tissue and hygiene industry. Our reports f...
Market research on the tissue and hygiene industry. Our reports feature standardised and cross-comparable total market sizes, market and brand share data, distribution and trends.
Tightened regulations for Rx/reimbursement adult incontinence products had a negative impact on volume sales in 2021. Furthermore, due to COVID-19 restrictions, patients who would normally have been diagnosed with incontinence were reluctant to visit…
Rx sales of adult incontinence continue to show strong growth in Kazakhstan in 2021. This primarily reflects the increase in average age of the population, as well as the fact that older consumers have been the most likely to be admitted to hospital…
The ongoing ageing of Denmark’s population continued to drive rising consumption, given that the elderly is the group most likely to experience incontinence. In addition, high obesity rates are also a factor driving value growth.
RX/reimbursement adult incontinence continued to decline in Italy in 2021 as a consequence of the spending review of the regional branches of the National Sanitary System. The Italian reimbursement scheme is an integral part of welfare assistance,…
RX/reimbursement adult incontinence is a more substantial category in Poland than retail adult incontinence and has continued to record stable demand during the pandemic. This was supported by an ageing population (with more older adults identifying…
In 2021, there were no changes to the regulatory frame regarding the number of incontinence products, per person, per year, that are covered by HZZO (Croatian medical system). Rules on subsidies are clearly stated in a legal guideline, which states…
The fact that Rx/reimbursement adult incontinence products are available free of charge through Sweden’s public healthcare system and generally considered necessities by those who use them has helped to shield this category from the fallout of the…
Rx/reimbursement adult incontinence was largely unaffected by the pandemic, as it is an essential product. In 2021, volume growth was on par with 2020, though value growth was higher, due to price rises. Moderate/heavy adult incontinence products…
Demographic factors such as the ageing population continue to drive sales of Rx/reimbursement adult incontinence products in Germany. However, since product availability within the reimbursement scenario is limited to what the insurance company can…
Rx/reimbursement adult incontinence registered both current value and volume growth in 2021. However, growth was lower than in 2020, as hospitals treated less older patients with COVID-19, who also suffered from incontinence issues. The Institute of…
Value sales of Rx/reimbursement adult incontinence have seen slightly slower growth since the outbreak of COVID-19, with the pandemic creating some short-term disruptions to access, with some consumers facing difficulty accessing healthcare…
Hungary’s ageing population provided opportunity for further category growth in 2021. The majority of people with incontinence visit the doctor only when the problem is quite severe, which means that education is important in terms of how they may…
Demand for Rx/reimbursement adult incontinence in Austria demonstrated stable growth in 2021, with no overall change in consumer purchase or usage patterns. Consumers aged 65+ accounted for over 20% of the Austrian population in 2021, with the…
Sales of Rx/reimbursement adult incontinence products continued to see solid volume growth in 2021, along with a slightly higher current value increase due to price rises. Like other hygiene categories, COVID-19 had little impact on the growth rates,…
With consumer behaviour returning to normal again in 2021, Rx/reimbursement incontinence recorded stronger growth. Being more active and away from home increased the need for incontinence products overall. Additionally, more consumers were willing to…
Rx/reimbursement adult incontinence recorded an upturn in demand over the course of 2021, driven by increasing price sensitivity as consumers looked to save money wherever possible, in addition to greater awareness of their entitlement to these…
A much larger category compared to retail adult incontinence in Turkey, RX/reimbursement adult incontinence recorded positive growth in demand in 2021. RX/reimbursement adult incontinence has been recording stronger demand than retail adult…
In similar trends noted in most retail hygiene products, rx/reimbursement adult incontinence in Serbia was completely unaffected by the emergence of COVID-19. This was because the category remained untouched by the pandemic in 2020, and therefore,…
PAMI (National Institute for Retirees and Pensioners) is the public institution in charge of providing health coverage to retirees and pensioners in the country. It is present through 650 subsidiaries throughout the country and has around 4.8 million…